Interleukin-9 Is Required for Allergic Airway Inflammation Mediated by the Cytokine TSLP

Immunity

Volumn 38, Issue 2, 2013, Pages 360-372

  Yao, Weiguo ^a   Zhang, Yanlu ^a,c   Jabeen, Rukhsana ^a   Nguyen, Evelyn T ^a   Wilkes, David S ^a,b   Tepper, Robert S ^a   Kaplan, Mark H ^a   Zhou, Baohua ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; INTERLEUKIN 9; INTERLEUKIN 9 ANTIBODY; NEUTRALIZING ANTIBODY; STAT5 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INFANT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TH2 CELL; TH9 CELL; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, NEUTRALIZING; CELL DIFFERENTIATION; CYTOKINES; DERMATITIS, ATOPIC; GENE EXPRESSION; HUMANS; INFANT; INFLAMMATION; INTERLEUKIN-9; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 84874241774     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.01.007     Document Type: Article

References (53)

1. Al-Shami A., Spolski R., Kelly J., Keane-Myers A., Leonard W.J. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 2005, 202:829-839.
2. Allakhverdi Z., Comeau M.R., Jessup H.K., Yoon B.R., Brewer A., Chartier S., Paquette N., Ziegler S.F., Sarfati M., Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 2007, 204:253-258.
3. Chang H.C., Sehra S., Goswami R., Yao W., Yu Q., Stritesky G.L., Jabeen R., McKinley C., Ahyi A.N., Han L., et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 2010, 11:527-534.
4. Cheng G., Arima M., Honda K., Hirata H., Eda F., Yoshida N., Fukushima F., Ishii Y., Fukuda T. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 2002, 166:409-416.
5. Cote-Sierra J., Foucras G., Guo L., Chiodetti L., Young H.A., Hu-Li J., Zhu J., Paul W.E. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 2004, 101:3880-3885.
6. Dakic A., Metcalf D., Di Rago L., Mifsud S., Wu L., Nutt S.L. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 2005, 201:1487-1502.
7. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R.A., Mitsdoerffer M., Strom T.B., Elyaman W., Ho I.C., et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 2008, 9:1347-1355.
8. Erpenbeck V.J., Hohlfeld J.M., Volkmann B., Hagenberg A., Geldmacher H., Braun A., Krug N. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J. Allergy Clin. Immunol. 2003, 111:1319-1327.
9. Fontenot D., He H., Hanabuchi S., Nehete P.N., Zhang M., Chang M., Nehete B., Wang Y.H., Wang Y.H., Ma Z.M., et al. TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells. Proc. Natl. Acad. Sci. USA 2009, 106:16776-16781.
10. Fung M.M., Chu Y.L., Fink J.L., Wallace A., McGuire K.L. IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1. Oncogene 2005, 24:4624-4633.
11. Goswami R., Kaplan M.H. A brief history of IL-9. J. Immunol. 2011, 186:3283-3288.
12. Goswami R., Jabeen R., Yagi R., Pham D., Zhu J., Goenka S., Kaplan M.H. STAT6-dependent regulation of Th9 development. J. Immunol. 2012, 188:968-975.
13. He R., Oyoshi M.K., Garibyan L., Kumar L., Ziegler S.F., Geha R.S. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc. Natl. Acad. Sci. USA 2008, 105:11875-11880.
14. Headley M.B., Zhou B., Shih W.X., Aye T., Comeau M.R., Ziegler S.F. TSLP conditions the lung immune environment for the generation of pathogenic innate and antigen-specific adaptive immune responses. J. Immunol. 2009, 182:1641-1647.
15. Houssiau F.A., Schandené L., Stevens M., Cambiaso C., Goldman M., van Snick J., Renauld J.C. A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. J. Immunol. 1995, 154:2624-2630.
16. Isaksen D.E., Baumann H., Trobridge P.A., Farr A.G., Levin S.D., Ziegler S.F. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J. Immunol. 1999, 163:5971-5977.
17. Ito T., Wang Y.H., Duramad O., Hori T., Delespesse G.J., Watanabe N., Qin F.X., Yao Z., Cao W., Liu Y.J. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 2005, 202:1213-1223.
18. Jabeen R., Kaplan M.H. The symphony of the ninth: the development and function of Th9 cells. Curr. Opin. Immunol. 2012, 24:303-307.
19. Jones C.P., Gregory L.G., Causton B., Campbell G.A., Lloyd C.M. Activin A and TGF-β promote TH9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol. 2012, 129:1000-1010.
20. Kearley J., Erjefalt J.S., Andersson C., Benjamin E., Jones C.P., Robichaud A., Pegorier S., Brewah Y., Burwell T.J., Bjermer L., et al. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am. J. Respir. Crit. Care Med. 2011, 183:865-875.
21. Kitajima M., Lee H.C., Nakayama T., Ziegler S.F. TSLP enhances the function of helper type 2 cells. Eur. J. Immunol. 2011, 41:1862-1871.
22. Kung T.T., Luo B., Crawley Y., Garlisi C.G., Devito K., Minnicozzi M., Egan R.W., Kreutner W., Chapman R.W. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am. J. Respir. Cell Mol. Biol. 2001, 25:600-605.
23. Lei L., Zhang Y., Yao W., Kaplan M.H., Zhou B. Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells. J. Immunol. 2011, 186:2254-2261.
24. Li M., Messaddeq N., Teletin M., Pasquali J.L., Metzger D., Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc. Natl. Acad. Sci. USA 2005, 102:14795-14800.
25. Liao W., Schones D.E., Oh J., Cui Y., Cui K., Roh T.Y., Zhao K., Leonard W.J. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat. Immunol. 2008, 9:1288-1296.
26. Omori M., Ziegler S. Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin. J. Immunol. 2007, 178:1396-1404.
27. Pandey A., Ozaki K., Baumann H., Levin S.D., Puel A., Farr A.G., Ziegler S.F., Leonard W.J., Lodish H.F. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 2000, 1:59-64.
28. Park L.S., Martin U., Garka K., Gliniak B., Di Santo J.P., Muller W., Largaespada D.A., Copeland N.G., Jenkins N.A., Farr A.G., et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 2000, 192:659-670.
29. Rochman I., Watanabe N., Arima K., Liu Y.J., Leonard W.J. Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. J. Immunol. 2007, 178:6720-6724.
30. Rochman Y., Kashyap M., Robinson G.W., Sakamoto K., Gomez-Rodriguez J., Wagner K.U., Leonard W.J. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc. Natl. Acad. Sci. USA 2010, 107:19455-19460.
31. Schmitt E., Germann T., Goedert S., Hoehn P., Huels C., Koelsch S., Kühn R., Müller W., Palm N., Rüde E. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 1994, 153:3989-3996.
32. Semlali A., Jacques E., Koussih L., Gounni A.S., Chakir J. Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway. J. Allergy Clin. Immunol. 2010, 125:844-850.
33. Sokol C.L., Barton G.M., Farr A.G., Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 2008, 9:310-318.
34. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 2002, 3:673-680.
35. Staudt V., Bothur E., Klein M., Lingnau K., Reuter S., Grebe N., Gerlitzki B., Hoffmann M., Ulges A., Taube C., et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010, 33:192-202.
36. Stritesky G.L., Kaplan M.H. Changing the STATus quo in T helper cells. Transcription 2011, 2:179-182.
37. Stritesky G.L., Muthukrishnan R., Sehra S., Goswami R., Pham D., Travers J., Nguyen E.T., Levy D.E., Kaplan M.H. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 2011, 34:39-49.
38. Temann U.A., Geba G.P., Rankin J.A., Flavell R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 1998, 188:1307-1320.
39. Temann U.A., Laouar Y., Eynon E.E., Homer R., Flavell R.A. IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 2007, 19:1-10.
40. Tepper R.S., Llapur C.J., Jones M.H., Tiller C., Coates C., Kimmel R., Kisling J., Katz B., Ding Y., Swigonski N. Expired nitric oxide and airway reactivity in infants at risk for asthma. J. Allergy Clin. Immunol. 2008, 122:760-765.
41. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., Martin B., Wilhelm C., Stockinger B. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008, 9:1341-1346.
42. Wang Y.H., Ito T., Wang Y.H., Homey B., Watanabe N., Martin R., Barnes C.J., McIntyre B.W., Gilliet M., Kumar R., et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006, 24:827-838.
43. Wilhelm C., Hirota K., Stieglitz B., Van Snick J., Tolaini M., Lahl K., Sparwasser T., Helmby H., Stockinger B. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 2011, 12:1071-1077.
44. Yao W., Barbe-Tuana F.M., Llapur C.J., Jones M.H., Tiller C., Kimmel R., Kisling J., Nguyen E.T., Nguyen J., Yu Z., et al. Evaluation of airway reactivity and immune characteristics as risk factors for wheezing early in life. J Allergy Clin Immunol. 2010, 126:483-488.
45. Yao W., Tepper R.S., Kaplan M.H. Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol. 2011, 128:1357-1360.
46. Ying S., Meng Q., Kay A.B., Robinson D.S. Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin. Exp. Allergy 2002, 32:866-871.
47. Ying S., O'Connor B., Ratoff J., Meng Q., Mallett K., Cousins D., Robinson D., Zhang G., Zhao J., Lee T.H., Corrigan C. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 2005, 174:8183-8190.
48. Yoo J., Omori M., Gyarmati D., Zhou B., Aye T., Brewer A., Comeau M.R., Campbell D.J., Ziegler S.F. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 2005, 202:541-549.
49. Yu Q., Thieu V.T., Kaplan M.H. Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18Ralpha gene during Th1 differentiation. EMBO J. 2007, 26:2052-2060.
50. Zhang Y., Zhou B. Functions of thymic stromal lymphopoietin in immunity and disease. Immunol. Res. 2012, 52:211-223.
51. Zhou B., Comeau M.R., De Smedt T., Liggitt H.D., Dahl M.E., Lewis D.B., Gyarmati D., Aye T., Campbell D.J., Ziegler S.F. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 2005, 6:1047-1053.
52. Zhou B., Headley M.B., Aye T., Tocker J., Comeau M.R., Ziegler S.F. Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses. J. Immunol. 2008, 181:6557-6562.
53. Zhu J., Cote-Sierra J., Guo L., Paul W.E. Stat5 activation plays a critical role in Th2 differentiation. Immunity 2003, 19:739-748.